In late April, the Department of Health approved a new anti-allergy medicine: Xolair. This drug, dubbed the first immune regulating drug in more than a century, was developed by Chang Tse-wen, a distinguished research fellow at the Genomics Research Center at Academia Sinica, who tells us that Xolair will not only benefit millions of allergy sufferers around the world, but will further reveal the mechanisms of allergies.
衛生署在 4 月底核准了抗過敏新藥── Xolair（索雷爾）──上市，這種號稱百餘年來第一個免疫調節藥物的研發者──中研院基因體研究中心研究員張子文說，「索雷爾」不僅造福全球數以百萬計的過敏族，也更進一步揭開了過敏的機制。